Dark

Check out our Dark Pool Levels

SRZN
Surrozen, Inc. Common
stock NASDAQ

At Close

Apr 28, 2026 3:59:56 PM EDT

30.97USD+3.406%(+1.02)105,480

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-29.95)0

After-hours

Apr 28, 2026 4:00:30 PM EDT

30.98USD+0.032%(+0.01)190

OverviewHistoricalExchangesShortsNews

Jan 10, 2022

08:00AM EST -Initiation of Phase 1 clinical trials of SZN-1326 and SZN-043 expected in third quarter 2022 GlobeNewswire Inc

Jan 5, 2022

08:00AM EST Surrozen, Inc. (Surrozen or the Company) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration,will present virtually on January 13, 2022 at 9 a.m. ET, at the 40th J.P. Morgan Healthcare Conference. GlobeNewswire Inc

Nov 15, 2021

04:04PM EST Surrozen Q3 EPS $(0.51) Down From $(0.47) YoY Benzinga

04:00PM EST Product Candidates SZN-1326 and SZN-043 Advance Toward Initiation of Clinical Studies in 2022 GlobeNewswire Inc

11:07AM EST Surrozen To Present At The Piper Sandler 33rd Annual Healthcare Conference Nov. 22 Benzinga

08:00AM EST Surrozen Presents Data Supporting Potential of SZN-043 at The GlobeNewswire Inc

08:00AM EST Surrozen to Present at The Piper Sandler 33rd Annual Healthcare GlobeNewswire Inc

Nov 5, 2021

08:00AM EDT Surrozen to Present at The Stifel 2021 Virtual Healthcare Conference GlobeNewswire Inc

Oct 11, 2021

10:51AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021 Benzinga

07:03AM EDT B of A Securities Initiates Coverage On Surrozen with Buy Rating, Announces Price Target of $11 Benzinga

Oct 7, 2021

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Oct 5, 2021

04:31PM EDT Surrozen Presented Data Supporting Potential Of SZN-1326 At The 2021 United European Gastroenterology Week Benzinga

04:30PM EDT Surrozen Presented Data Supporting Potential of SZN-1326 at the GlobeNewswire Inc

Sep 23, 2021

08:30AM EDT Surrozen Announces Appointment of Liz Nguyen as Vice President and GlobeNewswire Inc

Sep 15, 2021

10:05AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021 Benzinga

08:37AM EDT Guggenheim Initiates Coverage On Surrozen with Buy Rating, Announces Price Target of $20 Benzinga

Sep 12, 2021

04:04PM EDT The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs Benzinga

Sep 8, 2021

07:32AM EDT The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod Benzinga

Sep 7, 2021

02:32PM EDT Mid-Afternoon Market Update: Dow Falls Over 200 Points; RenovoRx Shares Spike Higher Benzinga

12:12PM EDT Mid-Day Market Update: Gold Drops 2%; Pliant Therapeutics Shares Jump Benzinga

10:11AM EDT Mid-Morning Market Update: Markets Open Lower; Avantor To Acquire Masterflex Benzinga

10:02AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021 Benzinga

07:42AM EDT Stifel Initiates Coverage On Surrozen with Buy Rating, Announces Price Target of $19 Benzinga

Share